Onsdag 29 Oktober | 12:00:21 Europe / Stockholm

Prenumeration

2025-10-23 17:26:00

Redeye keeps its Base Case and retains a positive view of Vertiseit following the Q3 report. While the q/q ARR growth was on the softer side following cautious customers in Q2, an encouraging outlook combined with deals in retail media suggests momentum is back on track.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/